Advertisement
| jto impact factor: Who Classification of Tumours of the Lung, Pleura, Thymus and Heart International Agency for Research on Cancer, 2015-03-16 WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart is the seventh volume in the Fourth Edition of the WHO series on histological and genetic typing of human tumors. This authoritative, concise reference book provides an international standard for oncologists and pathologists and will serve as an indispensable guide for use in the design of studies monitoring response to therapy and clinical outcome. |
| jto impact factor: Stereotactic Body Radiation Therapy Simon S. Lo, Bin S. Teh, Jiade J. Lu, Tracey E. Schefter, 2012-08-28 Stereotactic body radiation therapy (SBRT) has emerged as an important innovative treatment for various primary and metastatic cancers. This book provides a comprehensive and up-to-date account of the physical/technological, biological, and clinical aspects of SBRT. It will serve as a detailed resource for this rapidly developing treatment modality. The organ sites covered include lung, liver, spine, pancreas, prostate, adrenal, head and neck, and female reproductive tract. Retrospective studies and prospective clinical trials on SBRT for various organ sites from around the world are examined, and toxicities and normal tissue constraints are discussed. This book features unique insights from world-renowned experts in SBRT from North America, Asia, and Europe. It will be necessary reading for radiation oncologists, radiation oncology residents and fellows, medical physicists, medical physics residents, medical oncologists, surgical oncologists, and cancer scientists. |
| jto impact factor: Resistance to Tyrosine Kinase Inhibitors Daniele Focosi, 2016-11-14 The volume will serve as a primer on tyrosine kinase signaling and its importance in cancer. The volume will first introduce the common denominators of small-molecule and antibody-derived inhibitors, as well as the general phenomenon of resistance. The volume will then detail resistance to the most commonly used classes of tyrosine kinase inhibitors, and will focus specific chapters on resistance to BCR-ABL1, FLT3, angiokinase family members, and ALK inhibitors. |
| jto impact factor: Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA): a Practical Approach Sara E. Monaco, Walid E. Khalbuss, Liron Pantanowitz, 2014-05-22 This high-yield reference book focuses on the clinical, technical, and pathological aspects of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA). Its reviews cover all aspects of EBUS-TBNA, including the clinical perspective, technical aspects of the procedure, and cytomorphology of common and uncommon entities, as well as highlights diagnostic challenges. Each chapter features a multitude of full-color high-resolution images and includes key references to the current literature in the field. Additionally, reference tables and informative figures highlight the salient points. The book is unique in that it is written by experienced thoracic surgeons, pulmonary medicine physicians, and cytopathologists who use EBUS-TBNA in a large medical center. This publication is of interest to individuals learning and practicing cytopathology, in addition to clinicians practicing pulmonary/thoracic medicine or surgery. In short, it provides important pearls of wisdom to create a comprehensive reference for all physicians involved with EBUS-TBNA. |
| jto impact factor: Thymic Tumors R. Sarrazin, C. Vrousos, F. Vincent, 1989-01-20 |
| jto impact factor: THE ELEMENTS OF STYLE William Strunk Jr., 2018-11-02 This eBook has been formatted to the highest digital standards and adjusted for readability on all devices. The Elements of Style William Strunk concentrated on specific questions of usage—and the cultivation of good writing—with the recommendation Make every word tell; hence the 17th principle of composition is the simple instruction: Omit needless words. The book was also listed as one of the 100 best and most influential books written in English since 1923 by Time in its 2011 list. |
| jto impact factor: Light and Photosynthesis in Aquatic Ecosystems John T. O. Kirk, 2010-12-23 Beginning systematically with the fundamentals, the fully-updated third edition of this popular graduate textbook provides an understanding of all the essential elements of marine optics. It explains the key role of light as a major factor in determining the operation and biological composition of aquatic ecosystems, and its scope ranges from the physics of light transmission within water, through the biochemistry and physiology of aquatic photosynthesis, to the ecological relationships that depend on the underwater light climate. This book also provides a valuable introduction to the remote sensing of the ocean from space, which is now recognized to be of great environmental significance due to its direct relevance to global warming. An important resource for graduate courses on marine optics, aquatic photosynthesis, or ocean remote sensing; and for aquatic scientists, both oceanographers and limnologists. |
| jto impact factor: Cancer Survival and Prevalence in Australia Australian Institute of Health and Welfare, 2012 This report presents the latest national survival and prevalence statistics for cancers in Australia from 1982 to 2010. Survival from cancer is a key indicator of cancer prognosis, control and treatment. It refers to the probability of being alive for a given amount of time after diagnosis and reflects the severity of a cancer diagnosis. |
| jto impact factor: Thoracic Malignancies Steven E. Schild, MD, 2010-03-08 Thoracic Malignancies: Thoracic Malignancies is the first title in Radiation Medicine Rounds. These tumors take more lives than any others and they are among the most preventable of tumors. Thus it is crucial for the practitioner to be up-to-date on the latest insights regarding their management. Thoracic Malignancies addresses the multi-disciplinary nature of the care of these tumors. There is representation from radiation oncology, medical oncology, and surgery ensuring a well-rounded summarization of current practice. Included are chapters on lung cancer, esophageal cancer, and thymomas providing coverage of the vast majority of thoracic tumors. The multi-disciplinary nature of the articles provides readers with an up-to-date summary and a well-rounded review regarding these tumors and their care. Expert authors provide reviews and assessments of the most recent data and its implications for current clinical practice, along with insights into emerging new trends of importance for the near future. About the Series Radiation Medicine Rounds is an invited review publication providing a thorough analysis of new scientific, technologic, and clinical advances in all areas of radiation medicine. There is an emphasis throughout on multidisciplinary approaches to the specialty, as well as on quality and outcomes analysis. Published three times a year Radiation Medicine Rounds provides authoritative, thorough assessments of a wide range of Ïhot topicsÓ and emerging new data for the entire specialty of radiation medicine. Features of Radiation Medicine Rounds include: Editorial board of nationally recognized experts across the spectrum of radiation medicine In-depth, up-to-date expert reviews and analysis of major new developments in all areas of Radiation Medicine Issues edited by an authority in specific subject area Focuses on major topics in Radiation Medicine with in-depth articles covering advances in radiation science radiation medicine technology, radiation medicine practice, and assessment of recent quality and outcomes studies Emphasizes multidisciplinary approaches to research and practice |
| jto impact factor: Soviet Physics , 1983 |
| jto impact factor: IASLC Staging Handbook in Thoracic Oncology Ramon Rami-Porta, 2016-12-04 |
| jto impact factor: Lung Cancer Henry S. Park, 2021-06-02 Lung cancer continues to be the leading cause of cancer mortality worldwide among both men and women. Recent advances in prevention, screening and management in the past decade have led to significant improvements in survival and quality of life. Local treatments like minimally invasive surgery, radiotherapy, and image-guided ablation have contributed to improving the effectiveness and tolerability of potentially curative treatments in early-stage, locally advanced, and oligometastatic/oligoprogressive disease. Chemotherapy, targeted therapy, immunotherapy, and palliative local therapy options have expanded rapidly, with new regimens showing improved outcomes even for those with widely metastatic disease. This book comprehensively reviews the evidence that has driven personalized medicine, based on a variety of multidisciplinary perspectives by international lung cancer experts. |
| jto impact factor: Molecular Pathology of Lung Cancer Philip T. Cagle, Timothy Craig Allen, Mary Beth Beasley, Lucian R. Chirieac, Sanja Dacic, Alain C. Borczuk, Keith M. Kerr, 2012-06-14 As with other books in the Molecular Pathology Library Series, Molecular Pathology of Lung Cancer bridges the gap between the molecular specialist and the clinical practitioner, including the surgical pathologist who now has a key role in decisions regarding molecular targeted therapy for lung cancer. Molecular Pathology of Lung Cancer provides the latest information and current insights into the molecular basis for lung cancer, including precursor and preinvasive lesions, molecular diagnosis, molecular targeted therapy, molecular prognosis, molecular radiology and related fields for lung cancer generally and for the specific cell types. As many fundamental concepts about lung cancer have undergone revision in only the past few years, this book will likely be the first to comprehensively cover the new molecular pathology of lung cancer. It provides a foundation in this field for pathologists, medical oncologists, radiation oncologists, thoracic surgeons, thoracic radiologists and their trainees, physician assistants, and nursing staff. |
| jto impact factor: Tumors of the Thymus Juan Rosai, Gerald D. Levine, 1976 |
| jto impact factor: The American Cancer Society's Oncology in Practice The American Cancer Society, 2018-02-13 Developed by the American Cancer Society this new textbook designed for a wide range of learners and practitioners comprehensively addresses all aspects of clinical management for cancer taking a balanced, authoritative and, -where possible- evidence-based stance and may be used in conjunction with the book, The American Cancer Society's Principles of Oncology: Prevention to Survivorship. Edited by leading clinicians in the field and a stellar contributor list from the US and Europe, this book is written in an easy to understand style by multidisciplinary teams of medical oncologists, radiation oncologists and other specialists, reflecting day-to-day decision-making and clinical practice. Input from pathologists, surgeons, radiologists, and other specialists is included wherever relevant and comprehensive treatment guidelines are provided by expert contributors where there is no standard recognized treatment. This book is an ideal resource for anyone seeking a practical understanding of the field of oncology. |
| jto impact factor: Climate Change and Light in Aquatic Ecosystems: Variability & Ecological Consequences Patrick J. Neale, Oliver Zielinski, Rebecca L. North, Maren Striebel, Jochen Wollschläger, 2021-07-08 |
| jto impact factor: International Manual of Oncology Practice Ramon Andrade De Mello, Giannis Mountzios, Álvaro A. Tavares, 2019-10-15 Cancer is a very aggressive disease and currently it has been considered a challenge to oncologists and cancer patients worldwide. Nowadays, several therapeutic strategies had improved toward last decades. Surgery is many times still the best curative treatment, mainly in early stage disease. However, Radiotherapy and chemotherapy acquired a main role in this scenario. Target therapies were introduced for medical oncology practice and are demonstrating a hallmark of a new era in cancer treatment. More recently, immunotherapy has been considered the novel cornerstone in cancer treatment. The 2nd edition of the International Manual of Oncology Practice (iMOP) emerged after the great success of the iMOP 1st edition as a reference for medical oncologists and medical residents in the field. In this edition, several chapters were revised and its addresses from the molecular issues of cancer sciences to the clinical practice in medical oncology. In addition, multiple choice questions and clinical cases were included in the main chapters in order to improve the reader learning. The book focuses systemic treatments in many areas of medical oncology, such as breast cancer, gastrointestinal, thoracic, urological oncology, head and neck tumors, bone tumors, sarcomas and palliative care. The topics herein discussed will provide the readers a step forward in the medical oncology practice understanding and give facilities for help in cancer patient treatments. |
| jto impact factor: Thoracic Medicine Peter Emerson, 1981 |
| jto impact factor: Essentials of Clinical Radiation Oncology Matthew C. Ward, MD, Rahul D. Tendulkar, MD, Gregory M. M. Videtic, MD, CM, FRCPC, 2017-12-28 Essentials of Clinical Radiation Oncology is a comprehensive, user-friendly clinical review that summarizes up-to-date cancer care in an easy-to-read format. Each chapter is structured for straightforward navigability and information retention beginning with a “quick-hit” summary that contains an overview of each disease, its natural history, and general treatment options. Following each quick-hit are high-yield summaries covering epidemiology, risk factors, anatomy, pathology, genetics, screening, clinical presentation, workup, prognostic factors, staging, treatment paradigms, and medical management for each malignancy. Each treatment paradigm section describes the current standard of care for radiation therapy including indications, dose constraints, and side effects. Chapters conclude with an evidence-based question and answer section which summarizes practice-changing data to answer key information associated with radiation treatment outcomes. Flow diagrams and tables consolidate information throughout the book that all radiation oncologists and related practitioners will find extremely useful when approaching treatment planning and clinical care. Essentials of Clinical Radiation Oncology has been designed to replicate a house manual created and used by residents in training and is a one-stop resource for practicing radiation oncologists, related practitioners, and radiation oncology residents entering the field. Key Features: Offers digestible information as a learning guide for general practice Examines essential clinical questions which are answered with evidence-based data from important clinical studies Places clinical trials and data into historical context and points out relevance in current practice Provides quick reference tables on treatment options and patient selection, workup, and prognostic factors by disease site |
| jto impact factor: Tumors of the Lower Respiratory Tract Thomas V. Colby, Michael N. Koss, William D. Travis, Universities Associated for Research and Education in Pathology, 1995 |
| jto impact factor: Textbook of Uncommon Cancer Derek Raghavan, Manmeet S. Ahluwalia, Charles D. Blanke, Jubilee Brown, Edward S. Kim, Gregory H. Reaman, Mikkael A. Sekeres, 2017-03-03 The fifth edition of the only comprehensive text dealing exclusively with rare or infrequently encountered malignancies in adults and children is an essential resource for any clinical oncologist. Encompasses all the information needed to diagnose and manage uncommon cancers, an area where advice and guidance is typically scarce Fully revised with new material and an evidence-based, teach-by-example approach Provides insight on real-world decision making in the clinical setting Edited and authored by a highly experienced and senior team of medical oncologists, radiation oncologists, and other specialists, giving a balanced and complete overview Extensively illustrated in full color throughout, including heat maps to show gene expression |
| jto impact factor: TNM Supplement Christian Wittekind, James D. Brierley, Anne Lee, Elizabeth Van Eycken, 2019-07-12 The Union for International Cancer Controls (UICC) TNM classification system is the most widely used cancer classification and staging system in the world. It is used to describe the anatomical extent of disease and it is essential to patient care, research and cancer control. This fifth edition of the TNM Supplement: A Commentary of Uniform Use offers practitioners a wealth of material intended to complement the systems day-to-day use. The volume features: Updated definitions of terms used in cancer staging. New sections on carcinomas of the thymus, sarcomas of the spine and pelvis and soft tissue sarcomas of the head and neck, and comprehensive updates to the head and neck carcinomas, carcinomas of the lung and neuroendocrine tumours sections. Frequently asked questions from the UICC helpdesk. The Supplement may be treated as a companion text to the recent eighth edition of the TNM Classification of Malignant Tumours (978-1-119-26357-9), supporting the correct and uniform application of the TNM classification system. The TNM Supplement can also be utilised as a standalone book, providing explanations and examples to answer many questions that arise during the daily use of the TNM cancer classification and staging system, particularly in unusual cases. |
| jto impact factor: Lung Cancer Lynn T. Tanoue, Frank Detterbeck, 2018-06 Get a quick, expert overview of the many key facets of lung cancer evaluation and management with this concise, practical resource. This easy-to-read reference presents a summary of today's best evidence-based approaches to diagnosis and management in this critical area.-- |
| jto impact factor: Tumors of the Serosal Membranes Andrew Churg, Philip T. Cagle, Victor L. Roggli, 2006 The pathologist who sees specimens from lesions of the serosal membranes (pleura, pericardium, peritoneum, and tunica vaginalis) is well aware that these cases, whether in the form of fluid cytologies, small biopsies, or major resections, pose differential diagnostic problems that are among the most difficult in anatomic pathology. The main problems involve the separation of malignant mesothelioma from benign mesothelial processes on the one hand and other malignant tumours (particularly primary and metastatic carcinomas) on the other. With these differential diagnoses in mind, the authors concentrate on the cytopathologic and histopathologic features of diffuse malignant mesothelioma, its many variants, and the other benign and malignant lesions to be distinguished from it. Histochemical, immunohistochemical, ultrastructural and molecular features of potential use in this differentiation are discussed and illustrated. Common differential diagnostic problems and their solutions take precedence, but all of the known benign and malignant lesions of serosal membranes are covered, with copious illustrations and the latest available references. Epidemiologic, pathogenetic, clinical, radiographic and gross pathologic features are integrated with the discussions of these entities. This will be the most complete source available on this topic for years to come. |
| jto impact factor: Lung Cancer and Personalized Medicine Aamir Ahmad, Shirish Gadgeel, 2015-12-14 This, the first of two volumes on personalized medicine in lung cancer, touches on the core issues related to the understanding of lung cancer—statistics and epidemiology of lung cancer—along with the incidence of lung cancer in non-smokers. A major focus of this volume is the state of current therapies against lung cancer—immune, targeted therapies against EGFR TKIs, KRAS, ALK, angiogenesis; the associated challenges, especially resistance mechanisms; and recent progress in targeted drug development based on metal chemistry. Chapters are written by some of the leading experts in the field, who provide a better understanding of lung cancer, the factors that make it lethal, and current research focused on developing personalized treatment plans. With a unique mix of topics, this volume summarizes the current state-of-knowledge on lung cancer and the available therapies. |
| jto impact factor: Real-World Evidence in Lung Cancer Alfredo Addeo, Giuseppe Luigi Banna, Joshua Michael Bauml, Massimo Di Maio, 2021-09-24 |
| jto impact factor: Lung Cancer Alba Fabiola Costa Torres, 2018-10-31 Among the deadliest type of cancers, lung cancer faces several challenges in diagnosis and treatment: late diagnosis and misdiagnosis, inadequate tumor sampling, and resistance development to current therapies, among others. Together with advances in the understanding of molecular features, factors, and mechanisms involved in initiation and tumor progression, important improvements have occurred in diagnostics and therapeutics in the shape of advances in molecular genotyping, procedures for sampling, new potential, and less invasive sources of samples for the diagnosis and development of new targeted therapies. The aim of this book is to provide an exciting read on strategies in the diagnosis and therapy of lung cancer. |
| jto impact factor: Inventory of Water Resources Research in Australia , 1977 |
| jto impact factor: Intensity-Modulated Radiation Therapy S. Webb, 2015-05-06 Clinical conformal radiotherapy is the holy grail of radiation treatment and is now becoming a reality through the combined efforts of physical scientists and engineers, who have improved the physical basis of radiotherapy, and the interest and concern of imaginative radiotherapists and radiographers. Intensity-Modulated Radiation Therapy de |
| jto impact factor: Imaging in non-small cell lung cancer Yiyan Liu, Georgios S. Limouris, 2023-04-19 |
| jto impact factor: Chaotic Oscillators: Theory And Applications Tomasz Kapitaniak, 1992-11-30 This volume brings together a comprehensive selection of over fifty reprints on the theory and applications of chaotic oscillators. Included are fundamental mathematical papers describing methods for the investigation of chaotic behavior in oscillatory systems as well as the most important applications in physics and engineering. There is currently no book similar to this collection. |
| jto impact factor: Breakthrough in Imaging-Guided Precision Medicine in Oncology Laurent Dercle, Samy Ammari, Florent L. Besson, Fatima-Zohra Mokrane, Romain-David Seban, Randy Yeh, 2022-03-11 |
| jto impact factor: Factors that impact the survival of non-small cell lung cancer Kristin Higgins, Jessy Deshane, Fiona Hegi-Johnson, 2023-03-15 |
| jto impact factor: Histological Typing of Lung and Pleural Tumours W.D. Travis, L.H. Sobin, 1999 with contributions by Pathologists from 14 Countries |
| jto impact factor: Molecular Medicine and Biomedical Research in the Era of Precision Medicine Ranbir Chander Sobti, Douglas W Wilson, Harpal S. Buttar, Istvan G Telessy, Aastha Sobti, 2025-05-12 Molecular Medicine and Biomedical Research in the Era of Precision Medicine: New Technologies and Personalized Drug Therapies for Patient Care provides researchers with an extensive overview of recent advances in molecular biology impacting the development of targeted therapies. The book delivers insights into the pathobiological and pathogenetic mechanisms of various diseases, providing a detailed study of the latest personalized interventions to be implemented across such conditions. It covers a range of technologies, including RNA-sequencing, AI, Machine Learning, gene therapy, omics and nanotechnology, delving into their clinical applications across various diseases.The book also tackles targeted treatments of different disease types, including acute, chronic, infectious and noncommunicable diseases. Future perspectives are also covered, providing an in-depth study across molecular medicine, drug discovery and delivery, disease diagnosis and prevention, and therapeutic interventions, and acting as an invaluable interdisciplinary reference for researchers across the biomedical sciences. - Investigates the molecular basis and mechanisms of diseases, including cardiovascular, infectious, and neurological diseases - Presents molecular-based therapeutics for personalized treatment and the diagnosis of various conditions - Considers a range of technologies in the field of biomedicine and molecular medicine, including artificial intelligence and nanotechnology |
| jto impact factor: Pearson's Thoracic & Esophageal Surgery G. Alexander Patterson, 2008 Published as two individual books in its previous editions, this acclaimed reference now comes to you as one comprehensive two-volume resource, covering the entire range of esophageal and thoracic surgery for adults and children. Sixty nine brand-new chapters and 92 new authors deliver state-of-the-art, clear how-to-do-it guidance on the latest surgical techniques for the treatment of lung infections, lung cancer, benign conditions, trauma, reflux, and more-so you can effectively manage every common and uncommon condition you encounter. A new full-color design presents outstanding visual guidance that shows you exactly how to proceed, and a logical organization throughout makes reference easy. As an Expert Consult title, this thoroughly updated 3rd edition comes with access to the complete contents online, fully searchable-enabling you to consult it rapidly from any computer with an Internet connection. Addresses all surgical diseases of the chest wall, chest cavity, upper airway, lungs, pleura, and diaphragm in adults and children, giving you the comprehensive coverage you need for the patients you see. Presents clinical commentary at the end of each chapter that offers you a variety of viewpoints regarding the pros, cons, and complications associated with the techniques used to treat a patient. |
| jto impact factor: Alkylphosphocholines Hansjörg Eibl, 1992 |
| jto impact factor: Optimizing Outcomes and Addressing Adversities of Immunotherapy in Lung Cancer Jun Zhang, Oscar Arrieta, Jarushka Naidoo, 2023-10-06 |
| jto impact factor: Metastatic Cancer: Clinical and Biological Perspectives Rahul Jandial, 2013-08-08 Most cancer deaths are a result of metastasis. The spread of a primary tumor to colonize neighboring and distant organs is the relentless endgame that defines the neoplastic process. Patients who have been diagnosed with cancer are treated to prevent both the recurrence of the tumor at the site of origin and metastasis that would re-stage them as advanced stage IV cancer. Historically and still with some types of cancer, stage IV is perceived by patients as “terminal.” Fortunately, recent molecular therapies have extended the lives of patients with advanced cancer and reassuringly people living with metastatic disease increasingly visit our clinics. What is the path forward? Given that the consilience of science and medicine is a dynamic art from which therapies arise, it would be misguided to consider any single work adequate at capturing the horizon for research. So with humility we constructed this text as primer for scientists. It begins with a broad introduction to the clinical management of common cancers. This is intended to serve as a foundation for investigators to consider when developing basic science hypotheses. Unquestionably, medical and surgical care of cancer patients reveals biology and dictates how novel therapeutics will ultimately be evaluated in clinical trials. The second section of this text offers provocative and evolving insights that underscore the breadth of science involved in the elucidation of cancer metastasis biology. The text concludes with information that integrates scientific and clinical foundations to highlight translational research. This book serves as a framework for scientists to conceptualize clinical and translational knowledge on the complexity of disease that is metastatic cancer. |
| jto impact factor: Social Determinants of Health in Non-communicable Diseases Katsunori Kondo, 2021-11-04 This book is open access under a CC BY-NC-ND 4.0 license. This open access book is the first compilation that reviews a wide range of social determinants of health (SDHs) for non-communicable diseases (NCDs) and healthy ageing in Japan. With the highest life expectancy and the largest elderly population in the world, Japan has witnessed health inequality by region and social class becoming more prevalent since the 2000s. The first half of this volume describes in detail major NCDs, such as cancers, heart and kidney diseases, diabetes, stroke, and metabolic syndrome. The second half, on the other hand, explores various SDHs relating to healthy ageing. All chapters review and focus on SDHs, particularly health inequality associated with socio-economic status and social capital, which are widely addressed in the field of social epidemiology. The book makes the argument that “Health for All” advocated by the WHO should be implemented based on social justice and benefits for the greater society. Public health researchers and policymakers, both in Japan and other nations, will gain scientific evidence from this book to prepare for the coming era as ageing becomes a global issue. |
Home Page: Journal of Thoracic Oncology
Jan 24, 2025 · Journal of Thoracic Oncology (JTO), the official journal of the International Association for the Study of Lung Cancer, is the primary educational and informational …
Journal of Thoracic Oncology | ScienceDirect.com by Elsevier
Journal of Thoracic Oncology (JTO), the official journal of the International Association for the Study of Lung Cancer, is the primary educational and informational publication …
Home Page: JTO Clinical and Research Reports
Mar 20, 2025 · Founded in 1974, the association's membership includes more than 8,000 lung cancer specialists across all disciplines in over 100 countries, forming a …
Current Issue Table of Contents: Journal of Thoracic Oncology - jto…
Jan 30, 2025 · Can Immunotherapy Be Omitted in KRAS G12C-Mutant Lung Cancer by 2025? Gene Copy Deletion of STK11, KEAP1, and SMARCA4: Biomarker For “Cold” Tumor? Old …
Journal of Thoracic Oncology | All Journal Issues - ScienceDirect
Read the latest articles of Journal of Thoracic Oncology at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature
Home Page: Journal of Thoracic Oncology
Jan 24, 2025 · Journal of Thoracic Oncology (JTO), the official journal of the International Association for the Study of Lung Cancer, is the primary educational and informational …
Journal of Thoracic Oncology | ScienceDirect.com by Elsevier
Journal of Thoracic Oncology (JTO), the official journal of the International Association for the Study of Lung Cancer, is the primary educational and informational publication for topics …
Home Page: JTO Clinical and Research Reports
Mar 20, 2025 · Founded in 1974, the association's membership includes more than 8,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network …
Current Issue Table of Contents: Journal of Thoracic Oncology - jto…
Jan 30, 2025 · Can Immunotherapy Be Omitted in KRAS G12C-Mutant Lung Cancer by 2025? Gene Copy Deletion of STK11, KEAP1, and SMARCA4: Biomarker For “Cold” Tumor? Old …
Journal of Thoracic Oncology | All Journal Issues - ScienceDirect
Read the latest articles of Journal of Thoracic Oncology at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature
Articles in Press: Journal of Thoracic Oncology - jto.org
Jan 24, 2025 · Neoadjuvant or Perioperative Chemoimmunotherapy Treatment in Patients with Resectable NSCLC: Still an Open Question. Comments on Marinelli et al. J Thorac Oncol. …
JTO公式サイト | プロフェッショナルレスリングJTO公式サイト
プロフェッショナルレスリングJUST TAP OUT公式サイト。 最新ニュース・試合結果・スケジュール・選手・チケット・グッズ情報満載です。
Journals - IASLC
Jan 30, 2025 · JTO is among the top 5% of all oncology journals and the leading journal that is entirely focused on thoracic oncology. JTO and JTO CRR feature novel research about the …
Journal of Thoracic Oncology - US Elsevier Health
Journal of Thoracic Oncology (JTO), the official journal of the International Association for the Study of Lung Cancer, is the primary educational and informational publication for topics …
Professional Wrestling Just Tap Out - Wikipedia
JTO (also known as Professional Wrestling Just Tap Out) is a Japanese professional wrestling promotion and training facility owned by Taka Michinoku. [1] . The promotion places an …
